BSI-201

DRUG2 trials

Sponsors

Sanofi

Conditions

Ovarian Cancer

Phase 2

A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian Cancer

CompletedNCT01033123

SanofiOvarian Cancer

Start: 2009-12-31End: 2012-02-29Updated: 2016-03-17

A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Resistant Recurrent Ovarian Cancer

CompletedNCT01033292

SanofiOvarian Cancer

Start: 2009-12-31End: 2012-12-31Updated: 2016-03-17

Related Papers

Phase II Trials of Iniparib (BSI-201) in Combination with Gemcitabine and Carboplatin in Patients with Recurrent Ovarian Cancer

The Oncologist2023-01-3011 citations